Fig. 2
From: Autoantibodies against BAFF, APRIL or IL21 - an alternative pathogenesis for antibody-deficiencies?
Subgroup analysis. Panel (a) shows the results of the BAFF-ELISA assorted by clinical characteristics. Comparing the distribution of these data subsets with the results of the healthy donor cohort was unable to show a significant difference. In Panel (b) the BAFF-ELISA results are sorted according to their B cell phenotype. In Panel (c) and (d) the results of the APRIL-ELISA are grouped by clinical manifestations and (b) cell phenotypes respectively. Panel (e) and (f) show the subgroups analysis for IL-21. The statistical analysis for none of the above yielded a significant result